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Introduction {#sec001}
============

Severe fever with thrombocytopenia syndrome (SFTS) is an emerging hemorrhagic fever that was reported recently in rural areas of China. The causative agent of SFTS is a novel bunyavirus named SFTS virus (SFTSV), a novel *Phlebovirus* in the *Bunyaviridae* family. The disease is characterized by fever, thrombocytopenia and leukopenia, with a reported case-fatality rate ranging from 2.5% to 30% in different areas of endemicity \[[@pone.0132968.ref001]--[@pone.0132968.ref003]\].

The risk factors for fatal outcome of SFTS infection have been studied in China. Liu W et al reported that older age, decreased level of consciousness, and elevated levels of lactate dehydrogenase and creatine kinase were significantly associated with fatal outcome of SFTSV infection \[[@pone.0132968.ref004]\]. Fatal outcome of SFTSV was also believed to be associated with high viral RNA load in blood at admission, higher serum liver transaminase levels, more pronounced coagulation disturbances, and higher levels of acute phase proteins, cytokines, and chemokines.^3^ Similarity, Gai ZT et al reported that a period of 7--13 days after the onset of illness was the critical stage and the key risk factors that contributed to patient death were elevated serum aspartate aminotransferase, lactate dehydrogenase, creatine kinase, creatine kinase fraction, the appearance of CNS (central nervous system) symptoms, hemorrhagic manifestation, disseminated intravascular coagulation, and multi-organ failure \[[@pone.0132968.ref005]\]. Sun YL et al confirmed that Cytokines IL-1RA, IL-6, IL-10, G-CSF, IP-10, and MCP-1 were elevated in SFTS patients and produced at robust levels in fatal cases \[[@pone.0132968.ref006]\]. Between late April and mid-May 2014, a cluster of SFTSV infection occurred in southeastern China and three sisters contracted SFTSV infection and all of them deceased. This cluster informed us that death of SFTS patient may be probably related to genetic susceptibility.

Materials & Methods {#sec002}
===================

Case Definition and Sample Collection {#sec003}
-------------------------------------

According to "the diagnosis and treatment programs of severe fever with thrombocytopenia syndrome" issued by The Ministry of Health of China \[[@pone.0132968.ref007]\], a suspected SFTS patient is defined as having the following clinical signs and symptoms: acute onset of fever (≥38.0°C) and other symptoms (e.g. gastrointestinal symptoms, bleeding), epidemiological risk factors (being a farmer or being exposed to ticks two weeks before onset of illness) and laboratory data consisting of thrombocytopenia and leukopenia was defined as a suspected case. A laboratory confirmed cases of SFTSV infection were defined as those who met the criteria for having a suspected case of SFTS and detection of SFTSV RNA by a molecular method or isolation of SFTSV from the patient' blood or tissues.

Serum samples of suspected patients were collected within two weeks after onset of the illness and serum samples of family members, hospital staff who provided medical care for any of the patients and healthy persons living in the same areas with the patients were also collected. Moreover, ticks and serum samples of domesticated animals in the villages where patients lived were also collected.

Laboratory Investigation {#sec004}
------------------------

RNA was extracted from samples of suspected patients, ticks and domesticated animals using a high pure viral RNA kit according to the manufacturer's instructions. SFTSV M genomic segments were amplified using specific primers and probes by RT-PCR assay as described previously \[[@pone.0132968.ref008]\]. PCR products were sequenced on both strands by Shanghai Sangon Biotechnology Co. (Shanghai, China).

Serum samples of hospital staff, patients' family members, and healthy persons were tested for the presence of SFTSV specific IgG antibodies using an ELISA kit as described previously \[[@pone.0132968.ref009]\].

Epidemiological Investigation {#sec005}
-----------------------------

The aims of our study were explained to all patients and their consent was obtained prior to inclusion in this study. A standardized questionnaire was used to collect information about demographics, exposure history, clinical signs and symptoms, date of illness onset, date of first medical visit, date of hospitalization, date of specimen collection, and date of confirmation.

Phylogenetic Analyses {#sec006}
---------------------

Our sequences were compared to published sequences using the BLAST program from the National Center for Biotechnology Information Website (<http://www.ncbi.nlm.nih.gov/BLAST/>), and phylogenic analysis was performed using MEGA 4.0. For each gene analyzed, a phylogram was constructed by the neighbor-joining method. Confidence values for individual branches of the resulting tree were determined by bootstrap analysis with 1000 replicates.

Ethics Statement {#sec007}
----------------

Experimental research reported in this study has been performed with the approval of the ethics committee of Zhejiang Provincial Centre for Disease Control and Prevention (Zhejiang CDC). Human research was carried out in compliance with the Helsinki Declaration. All adult subjects provided informed consent, and a parent or guardian of any child participant provided informed consent on their behalf, and informed consent given was written. The individuals\' next-of kin have given written informed consent to publish these case details.

Results {#sec008}
=======

Patients {#sec009}
--------

The cluster of SFTSV infection occurred in Linhai County, Zhejiang Province which locates in southeastern China. On April 17, 2014, a 62-year-old woman (case A) had sudden onset of fever (38.5°C), fatigue, myalgia, headache, anorexia, and abdominal pain and she was treated with cefradine and archie enzyme at the town hospital ([Table 1](#pone.0132968.t001){ref-type="table"}). On April 19, she visited a county hospital in Linhai County and then she was admitted to a municipal hospital on April 20. On April 22, she developed high fever (39.2°C), obnubilation and septic shock and laboratory testing performed revealed leukopenia (WBC count, 1.0×10^9^/L) and thrombocytopenia (PLT count, 39×10^9^/L). The next day, she died of pulmonary hemorrhage and multi-organ failure ([Fig 1](#pone.0132968.g001){ref-type="fig"}). Serum sample of the patient was collected in the morning of April 23 and was confirmed to positive for SFTSV in the evening.

![Timelines of key events for three SFTSV infections in southeastern China.](pone.0132968.g001){#pone.0132968.g001}
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###### The Clinical features of patients involved in a family cluster occurred in 2014, Southeastern China.

![](pone.0132968.t001){#pone.0132968.t001g}

                                                                  Case A                                                 Case B                                                                         Case C
  --------------------------------------------------------------- ------------------------------------------------------ ------------------------------------------------------------------------------ ------------------------------------------------------
  General information                                                                                                                                                                                   
  Age, years and gender                                           62, female                                             65, female                                                                     79, female
  Occupation                                                      Farmer                                                 Farmer                                                                         Farmer
  Relationship with Case A                                        NA                                                     Second sister                                                                  Eldest sister
  Clinical manifestations                                                                                                                                                                               
  Date of onset                                                   April 17                                               April 18                                                                       April 28
  Date of first medical visit                                     April 17                                               April 18                                                                       April 28
  Date of hospitalization                                         April 20                                               April 18                                                                       May 5
  Date of specimen collection                                     April 23                                               April 23                                                                       May 6
  Date of confirmation                                            April 23                                               April 23                                                                       May 7
  Date of death                                                   April 23                                               April 27                                                                       May 13
  Max temperature (°C)[\*](#t001fn001){ref-type="table-fn"}       39.2                                                   39.2                                                                           39.1
  Symptoms                                                        Fatigue, myalgia, headache, anorexia, abdominal pain   Fatigue, conjunctival congestion, nausea, vomiting, abdominal pain, diarrhea   Fatigue, anorexia, nausea, vomiting, lymphadenopathy
  Blood counts                                                                                                                                                                                          
  White-cell count (109/L)[\*](#t001fn001){ref-type="table-fn"}   1                                                      0.8                                                                            1.4
  Platelets count (109/L)[\*](#t001fn001){ref-type="table-fn"}    39                                                     25                                                                             24
  Underlying diseases                                             NA                                                     NA                                                                             Hypertension, heart diseases

\*Data are peak or nadir measurement during hospitalization

Case B, the second sister of case A, was a female farmer aged 65. She had onset of fever, fatigue, conjunctival congestion, nausea, vomiting, abdominal pain, and diarrhea on April 18. She was admitted to a municipal hospital in Ningbo City which is adjacent to Linhai County on the same day. As the illness became worse, family members requested to withdraw intensive medical support, taking her home on April 26, where she deceased the next day ([Fig 1](#pone.0132968.g001){ref-type="fig"}).

Case C, the eldest sister of case A and case B, had onset of fatigue on April 28. She visited a town hospital from April 28 to May 3. On May 5, she was admitted to a local county hospital because of fever (39.1°C), fatigue, anorexia, nausea, and vomiting. In the hospital, she was treated with ribavirin and levofloxacin.

She deceased on May 13 because of multi-organ failure ([Fig 1](#pone.0132968.g001){ref-type="fig"}). Of note, she had underlying diseases including hypertension and heart diseases whereas case A and case B didn't have underlying diseases.

Epidemiological Investigations {#sec010}
------------------------------

Case A and case B picked tea leaves from April 8 to April 12 in a hilly area around the village where case B used to live in. Then case A return to her home in another town and case B visited her daughter in Ningbo City on April 13 ([Fig 1](#pone.0132968.g001){ref-type="fig"}). Ecological survey revealed no obvious change in mosquito density nor rising morbidity or mortality of domesticated animals at that time was observed in the village. But ticks were found in the tea garden where the sisters worked and body surfaces of cattle in the village and 92 *Haemaphysalis longicornis* adult ticks were collected in this area.

Case C used to live with her daughter's family in Changxing County which locates in northwestern Zhejiang Province before April 23. She went to Linhai County on April 23 and lived there that night. Then she went to Ningbo City and visited case B on April 24. Because she was afraid to contract the disease from case B, she didn't closely contact with case B and leaved the ward not more than 10 minutes. On April 25, she went back to her hometown in Linhai County, another village belong to the same town of case B's hometown and lived at her home until May 5 ([Fig 1](#pone.0132968.g001){ref-type="fig"}). 88 *Haemaphysalis longicornis* nymph ticks were collected around the house where she lived in Linhai.

Laboratory Investigations {#sec011}
-------------------------

SFTSV M genomic segments were detected in three groups of ticks which comprised 45 nymph ticks around the house of case C. No SFTSV M genomic segments were found in ticks from the tea garden and body surfaces of cattle in the village of case B, serum samples of 7 chickens, 6 dogs, 5 cows and 3 ducks from case C' home. As shown in [Fig 2](#pone.0132968.g002){ref-type="fig"}, SFTSV M genomic segment of case C (ZJ2014P-3) were closely related to corresponding segments from the three tick groups (ZJ2014T-1, ZJ2014T-2, ZJ2014T-3) and corresponding segments from Jiangsu Province, Shandong Province, Henan Province, and Liaoning Province. SFTSV M genomic segment of case A (ZJ2014P-1) was most similar to corresponding segments from Japan and Zhoushan City which lies in the northeast of Zhejiang Province. But sequences of case A, case C, and corresponding sequences from other provinces were possessed high degrees of similarity between nucleotide (95%-99%).

![Phylogenetic analyses of SFTSV M genomic segments identified in patients and ticks.](pone.0132968.g002){#pone.0132968.g002}

SFTSV specific IgG antibodies were found in 2 of 47 serum samples from healthy persons living in the same areas and 1 (the son of case C) of 16 serum samples from family members. No SFTSV specific IgG antibodies were found in 11 serum samples from hospital staff who provided medical service for the patients.

Discussion {#sec012}
==========

Here, we reported a cluster of SFTSV infection in southeastern China. Three sisters contracted the disease and all of them deceased. Investigation studies revealed that they were infected with SFTSV through tick bites and no person-to-person transmission occurred. Firstly, case A and case B had obvious exposure history of picking tea leaves from April 8 to April 12 and ticks were collected around the tea garden. Secondly, Case A and case B developed the disease 5--10 days after the exposure which was compatible with the incubation period of SFTSV infection. Thirdly, although case C had history of visiting case B, she didn't closely contact with her and the visit was brief. Fourthly, ticks were collected around the house where case C lived and SFTSV specific segments were found in these ticks. Finally, phylogenetic analyses revealed that SFTSV M genomic segment of case C was identical to corresponding segments from ticks collected around her residential place and sequences of case A and case C were not identical.

Of interesting, these three sisters lived in different cities before the cluster occurred. Case A lived in Linhai County, case B lived with her daughter's family in Ningbo City, and Case C lived in Changxing County. But they were all infected with SFTSV through tick bites and all deceased. Case B only lived in Linhai County for five days and case C only lived in Linhai County for four days before the illness onset. These findings suggested that genetic susceptibility was one of determinants for SFTSV infection and fatal outcome. Firstly, all three sisters contracted the disease and deceased, but seroprevalence of SFTSV IgG indicated that only 4.05% (3/74) of samples from individuals living in the same areas were seropositive. Moreover, the SFTSV infection of individuals whose samples were seropositive was asymptomatic. Secondly, there was no obvious mutation in SFTSV detected from case A and case C although they were not identical. Sequences of case A, case C, and corresponding sequences from other provinces were possessed high degrees of similarity between nucleotide (95%-99%). These findings indicated that the infection and fatal outcome of three sisters were not related to virus mutation. Thirdly, many clusters of SFTSV infection were reported in China and these studies showed that SFTSV infection of family members of patient was very common \[[@pone.0132968.ref010]--[@pone.0132968.ref016]\]. Furthermore, another study reported that seroprevalence of SFTSV among people who were family members of patient was significantly high. Fourthly, some viruses have been confirmed to be more easily transmitted between individuals with genetic connection \[[@pone.0132968.ref017]\]. For example, genetic susceptibility is one of determinates for Hantaan virus, Dengue virus, West Nile virus, H5N1, and H1N1 infection \[[@pone.0132968.ref018]--[@pone.0132968.ref023]\]. Finally, underlying diseases might be risk factors for SFSTV infection and fatal outcome. But case A and case B didn't have underlying diseases. We could rule out the influence of underlying diseases for the infection and death of case A and case B.

There were several limitations to our study. Firstly, we could not isolate virus from patients and ticks. Secondly, we could not get viral sequence of case B. Therefore, we didn't know the similarity of corresponding sequences of case A and case B. Thirdly, all three patients deceased and samples of them were very limited which prevent further study on genetic susceptibility of the disease. Finally, other factors may be contributed to SFTSV infection and fatal outcome. For example, life style (tea peaking), high positive rate of ticks in their living areas and fatigue might also be the determinants for SFTSV infection. Furthermore, the death of case A could make a great affection on case B and case C, especially for B who shared a common tea leaves picking experience with A. After case A died, case C who was 79 years old with hypertension and heart diseases, traveled from Changxing to Linhai, Ningbo and Linhai in three days, which was a great challenge to her body and psychology. These factors might also be attributed to fatal outcome. Further research should be conducted identify other determinants for SFTSV infection and fatal outcome.

To the best of our knowledge, this is the first report about genetic susceptibility of SFTSV infection. Our findings mean that genetic susceptibility is one of determinants for severe fever with thrombocytopenia syndrome virus infection and fatal outcome. These indicated that once a person was infected with SFTSV, his family members had a greater chance to be infected with SFTSV. Further study should be done to study genetic predisposition of SFTSV infection.
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